GW&K Investment Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10K | Buy |
362
+168
| +87% | +$4.64K | ﹤0.01% | 853 |
|
|
2025
Q1 | $5K | Buy |
194
+34
| +21% | +$876 | ﹤0.01% | 912 |
|
|
2024
Q4 | $7K | Buy |
160
+10
| +7% | +$438 | ﹤0.01% | 846 |
|
|
2024
Q3 | $10K | Sell |
150
-14
| -9% | -$933 | ﹤0.01% | 784 |
|
|
2024
Q2 | $19K | Buy |
164
+39
| +31% | +$4.52K | ﹤0.01% | 580 |
|
|
2024
Q1 | $13K | Buy |
125
+9
| +8% | +$936 | ﹤0.01% | 634 |
|
|
2023
Q4 | $12K | Sell |
116
-1
| -0.9% | -$103 | ﹤0.01% | 629 |
|
|
2023
Q3 | $12K | Buy |
117
+5
| +4% | +$513 | ﹤0.01% | 576 |
|
|
2023
Q2 | $14K | Buy |
112
+110
| +5,500% | +$13.8K | ﹤0.01% | 526 |
|
|
2023
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 556 |
|
|
2022
Q3 | – | Sell |
-42
| Closed | -$6K | – | 675 |
|
|
2022
Q2 | $6K | Buy |
42
+20
| +91% | +$2.86K | ﹤0.01% | 562 |
|
|
2022
Q1 | $4K | Buy |
+22
| New | +$4K | ﹤0.01% | 586 |
|